These are supplementary materials for the paper Computational Drug Repositioning and Elucidation of Mechanism of Action of Compounds against SARS-CoV-2 (preprint available at https://arxiv.org/abs/2004.07697). Included files: gene2drug_ACE2TMPRSS2.xls Results of the gene2drug analysis for drugs downregulating ACE2 and TMPRSS2 gene2drug_interactors.xls Results of the gene2drug analysis for drugs down-regulating human SARS-CoV-2 interactors MANTRA_COVID19_Inverse.xlsx Results of the MANTRA analysis for drugs reverting SARS-CoV-2 induced expression profile PEPs_CMap_msigDB7-covid.zip CMap expression profiles converted to Pathway Expression Profiles using the Gep2pep package (https://bioconductor.org/packages/...
The supplementary table S1-S7 of our paper entitled "In vivo structural characterization of the SARS...
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at present. Although...
Drug repurposing for COVID-19 has several potential benefits including shorter development time, red...
These are supplementary materials for the paper Computational Drug Repositioning and Elucidation of ...
Abstract The novel SARS-CoV-2 virus emerged in December 2019 and has few effective treatments. We ap...
The novel SARS-CoV-2 virus emerged in December 2019 and has few effective treatments. We applied a c...
Supplementary materials for the bioRxiv preprint "Genome-wide bioinformatic analyses predict key hos...
The global health pandemic known as COVID-19, which stems from the severe acute respiratory syndrome...
SARS-Cov-2 has emerged highly contagious viral infections so far and posed a global threat with sign...
The first patient of Coronavirus disease 2019 (COVID-19) was detected in December 2019. This infecti...
Although COVID-19 emerged as a major concern to public health around the world, no licensed medicati...
Drug repurposing has emerged as an important strategy and it has a great potential in identifying th...
SARS-CoV-2 has caused COVID-19 outbreak with nearly 2 M infected people and over 100K death worldwid...
SARS-CoV-2 infectivity is largely determined by the virus Spike protein binding to the ACE2 receptor...
SARS-CoV-2 infectivity is largely determined by the virus Spike protein binding to the ACE2 receptor...
The supplementary table S1-S7 of our paper entitled "In vivo structural characterization of the SARS...
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at present. Although...
Drug repurposing for COVID-19 has several potential benefits including shorter development time, red...
These are supplementary materials for the paper Computational Drug Repositioning and Elucidation of ...
Abstract The novel SARS-CoV-2 virus emerged in December 2019 and has few effective treatments. We ap...
The novel SARS-CoV-2 virus emerged in December 2019 and has few effective treatments. We applied a c...
Supplementary materials for the bioRxiv preprint "Genome-wide bioinformatic analyses predict key hos...
The global health pandemic known as COVID-19, which stems from the severe acute respiratory syndrome...
SARS-Cov-2 has emerged highly contagious viral infections so far and posed a global threat with sign...
The first patient of Coronavirus disease 2019 (COVID-19) was detected in December 2019. This infecti...
Although COVID-19 emerged as a major concern to public health around the world, no licensed medicati...
Drug repurposing has emerged as an important strategy and it has a great potential in identifying th...
SARS-CoV-2 has caused COVID-19 outbreak with nearly 2 M infected people and over 100K death worldwid...
SARS-CoV-2 infectivity is largely determined by the virus Spike protein binding to the ACE2 receptor...
SARS-CoV-2 infectivity is largely determined by the virus Spike protein binding to the ACE2 receptor...
The supplementary table S1-S7 of our paper entitled "In vivo structural characterization of the SARS...
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at present. Although...
Drug repurposing for COVID-19 has several potential benefits including shorter development time, red...